Rafarma Pharmaceuticals announced that it entered into a production agreement last month to manufacture Para-Aminosalicylic Acid (PAS), which is to be marketed and distributed by OOO Advance Trading.
Rafarma aims to work with federal initiatives to fast track the modernization of Russia’s pharmaceutical industry. It produces generic antibiotics, specialty pharmaceuticals, and its own line of proprietary products, which have been approved by the Russian Federation’s Ministry of Health.
Working with Advanced Trading will allow Rafarma to increase production of PAS and to become one of the leading PAS suppliers throughout the Russian market.
As one of Russia’s leading PAS distributors, Advance Trading is currently responsible for approximately 20% of sales in the Russian market. In 2011, the PAS market in Russian Federation was over than $8.2 billion dollars, according to data provided by DSM Group (a leading pharmaceutical market analyst).
Rafarma Pharmaceuticals’ CEO, Dave Anderson, remarked, “This new contract is yet another expansion of Rafarma’s production capability, opening the door for more revenue.”
For more information, visit www.Rafarma.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment